Title Assistant Professor of Medicine Institution Beth Israel Deaconess Medical Center Address Richard A. and Susan F. Smith
Center for Outcomes Research in Cardiology, MASCO 4
375 Longwood Ave.
Boston MA 02215
|
|
Biography
| Yale University, New Haven, CT | B.S. | 05/2007 | Biology |
| Harvard Medical School, Boston, MA | M.D. | 05/2011 | Medicine |
| Massachusetts General Hospital, Boston, MA | | 06/2014 | Internship and Residency in Internal Medicine |
| Beth Israel Deaconess Medical Center, Boston, MA | | 06/2017 | Fellowship in Cardiovascular Disease |
| Beth Israel Deaconess Medical Center, Boston, MA | | 06/2017 | Chief Fellow, Division of Cardiovascular Medicine |
| Harvard T.H. Chan School of Public Health, Boston, MA | M.Sc. | 05/2018 | Epidemiology |
2008
Boston Based Community Service Fellowship
2012
Principal Clinical Experience Teaching Award
2012
Department of Medicine Resident Research Award
2013
Citation for Excellence in Teaching Award
2014
Senior Resident Excellence in Teaching Award
2015
Fellowship in Training Travel Award
2018
Early Career Travel Award for Conference on Diagnostic Testing in Older Adults with CVD
2018
Best of AHA QCOR abstract
2020
AHA QCOR Early Career Investigator Semi-Finalist
2021
Brian Haluska Sonographer Research Award Finalist
2021
AHA QCOR Early Career Investigator Finalist
2021
Greater Boston NIH/NIA MSTAR at Harvard Mentor of the Year Award
Overview
Dr. Jordan Strom is Assistant Professor of Medicine at Harvard Medical School, Director of the Echocardiography Laboratory, and Director of Echocardiographic Research at Beth Israel Deaconess Medical Center in Boston, Massachusetts, and Section Head for Cardiovascular Imaging Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. His research which has been funded by the NIH and American Heart Association involves evaluation of the relationship of cardiac structure and function to health outcomes and the optimal use and timing of cardiac imaging in practice. He has published more than 70 papers in peer-reviewed journals, is a member of the Editorial Board of the Journal of the American Society of Echocardiography, and serves as Guest Editor for the Journal of the American Society of Echocardiography and the Journal of Cardiovascular Magnetic Resonance. He additionally was the inaugural American Society of Echocardiography (ASE) leadership academy member elected to the Board of Directors of the ASE and previously served on the American College of Cardiology Imaging Council Leadership Committee. He currently serves on the Board of Directors of the International Contrast Ultrasound Society, and is the current American College of Cardiology representative to the Board of Directors of the Joint Review Committee on Education in Diagnostic Medical Sonography, which accredits sonography training programs in the United States. Additionally, he is the American College of Cardiology Commissioner to CAAHEP, the largest accreditor of allied health professions in the United States.
Research
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
Faculty can
login
to make corrections and additions.
-
1R01HL169517-01
(Jordan Strom)
Jul 1, 2023 - Jun 30, 2028
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)
Role Description: This study seeks to understand the risk factors that are most important in AS progression as well as identify ways to identify those who progress more quickly and how AS progression associates with adverse cardiovascular outcomes using data from Chronic Renal Insufficiency Cohort Study, an NIDDK-sponsored population cohort study of individuals with chronic kidney disease, and the Atherosclerosis in Communities Study, an NHLBI-sponsored population cohort study of individuals, the majority of whom have normal kidney function.
-
3K23HL144907
(Jordan Strom)
Jul 1, 2023 - Jun 30, 2024
Frailty, Aging, and Risk of Adverse Outcomes in Mitral Valve Prolapse (FAR-OUT-MVP) Study
Role Description: This study represents an administrative supplement responsive to the CAROL Act (NOT-HL-23-078). The study uses the linkage of two unique data sources, imaging information from cardiac magnetic resonance images and echocardiograms from Beth Israel Deaconess Medical Center, and Massachusetts all-payer claims data to understand how the risks of adverse outcomes associated with MVP vary according to an individual’s age and underlying frailty status.
-
1R01AG063937
(Tobias Gerhardt)
Apr 1, 2020 - Mar 31, 2025
A Novel Approach to Examine Within-Class Therapeutic Exchangeability of Medications
Role Description: The goal of this study is to develop and test a novel approach to evaluate within-class therapeutic exchangeability of medications by employing an instrumental variable technique that exploits national variation in medications included on Medicare formulary tiers to evaluate the comparative effectiveness of different pharmaceuticals on a range of effectiveness and safety outcomes.
-
1K23HL144907
(Jordan Strom)
Jul 1, 2019
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling
Role Description: The goal of this study is to identify the elements of frailty that confer risk in patients undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) using linkage of Medicare claims to data from the US CoreValve Pivotal Trials to identify claims that best associate with frailty, identify if these frailty claims identify a heterogeneous treatment effect among those randomized to TAVR or SAVR, and use metabolomics in a prospectively enrolled TAVR population to identify a biomarker for frailty, as defined by comprehensive geriatrics assessments.
-
18CDA34110267
(Strom)
Jul 1, 2018 - Jun 30, 2019
American Heart Association
Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling
Role Description: The goal of this study is to identify the elements of frailty that confer risk in patients undergoing transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) using linkage of Medicare claims to data from the US CoreValve Pivotal Trials to identify claims that best associate with frailty, identify if these frailty claims identify a heterogeneous treatment effect among those randomized to TAVR or SAVR, and use metabolomics in a prospectively enrolled TAVR population to identify a biomarker for frailty, as defined by comprehensive geriatric assessments.
-
1F32HL140711-01
(Jordan Strom)
Jan 8, 2018 - Jan 7, 2020
Linking Clinical Trial and Registry Data to Evaluate Risks and Benefits of Aortic Valve Replacement (AVR) Strategies
Role Description: While treatments continue to advance for aortic stenosis, a fatal and common condition that affects many elderly adults, it is unclear who benefits most from newer transcatheter aortic valve replacement (TAVR) therapies versus traditional surgical aortic valve replacement. Our research aims to link trial and registry data to improve a physician’s ability to predict specific benefits and risks within certain subgroups of individuals. We will validate the use of this new approach, linking claims and trial data, as a novel method to capture information on trial participants and improve the ability to find subgroups with the most benefit/harm to treatments.
Bibliographic
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.